Share This Page
Drug Price Trends for ANNOVERA
✉ Email this page to a colleague
Average Pharmacy Cost for ANNOVERA
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| ANNOVERA VAGINAL RING | 68308-0752-01 | 2316.50957 | EACH | 2026-06-17 |
| ANNOVERA VAGINAL RING | 68308-0752-01 | 2316.41792 | EACH | 2026-05-20 |
| ANNOVERA VAGINAL RING | 68308-0752-01 | 2316.68021 | EACH | 2026-04-22 |
| ANNOVERA VAGINAL RING | 68308-0752-01 | 2317.30580 | EACH | 2026-03-18 |
| ANNOVERA VAGINAL RING | 68308-0752-01 | 2314.21220 | EACH | 2026-02-18 |
| ANNOVERA VAGINAL RING | 68308-0752-01 | 2315.07830 | EACH | 2026-01-21 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for ANNOVERA
Introduction
ANNOVERA, a revolutionary contraceptive developed by the Population Council and marketed by TherapeuticsMD, is the first and only FDA-approved, long-lasting, reversible, and procedure-free birth control method. Here, we delve into the market analysis and price projections for this innovative product.
FDA Approval and Market Launch
ANNOVERA was approved by the FDA in August 2018, marking a significant milestone in women's health care. The product was commercially launched in the fourth quarter of 2019, making it available to women in the U.S. market[1][4].
Market Adoption and Growth
Since its launch, ANNOVERA has seen steady adoption. In the third quarter of 2022, ANNOVERA prescriptions grew by 10% year-over-year, with over 15,000 healthcare providers prescribing the product. This growth indicates increasing acceptance and demand among both healthcare providers and patients[3].
Pricing and Affordability
The cost of ANNOVERA is a critical factor in its market analysis. As of the latest data, the price for one ANNOVERA vaginal ring is approximately $2,558, which is a significant expense for many consumers. However, TherapeuticsMD offers reduced pricing to federally designated Title X family planning clinics, making it more accessible to lower-income women[2][4].
Discounts and Assistance Programs
To make ANNOVERA more affordable, various discount programs and patient assistance initiatives are available. For instance, the Drugs.com Discount Card can save consumers up to 80% off the cost of prescription medicines, including ANNOVERA. Additionally, TherapeuticsMD may offer copay cards and other patient assistance programs to reduce the financial burden on patients[2].
Financial Performance
In the third quarter of 2022, ANNOVERA generated $10.4 million in net product revenue, although this was a decrease from the $11.8 million in the third quarter of 2021. Despite this, the company remains optimistic about the product's potential, citing growth in prescriber bases and patient demand[3].
Clinical Efficacy and User Satisfaction
ANNOVERA's effectiveness and user satisfaction are key drivers of its market success. Clinical trials have shown that ANNOVERA is 97.3% effective in preventing pregnancy when used as directed. Additionally, nearly 9 in 10 women surveyed in Phase 3 clinical trials were satisfied with ANNOVERA, praising its convenience, ease of use, and comfort[4].
Competitive Landscape
In the contraceptive market, ANNOVERA stands out due to its unique features: it is the only long-lasting, reversible, and procedure-free birth control method available. This differentiation helps it compete effectively against other hormonal contraceptives, although it faces competition from other forms of birth control such as pills, patches, and intrauterine devices (IUDs).
Price Projections
Given the current market dynamics and the product's unique selling points, here are some price projection considerations:
Short-Term Projections
- Stability in Pricing: In the short term, the price of ANNOVERA is likely to remain stable, as the product is still in its growth phase and the company is focused on increasing market penetration rather than adjusting prices.
- Discounts and Promotions: TherapeuticsMD may continue to offer discounts and promotional programs to make the product more accessible, especially to lower-income women and through Title X clinics.
Long-Term Projections
- Market Competition: As more competitors enter the market with similar products, there could be downward pressure on prices. However, ANNOVERA's unique features are likely to maintain its premium pricing.
- Economies of Scale: As production and sales volumes increase, TherapeuticsMD may benefit from economies of scale, potentially leading to reduced manufacturing costs and, subsequently, lower prices for consumers.
- Regulatory and Policy Changes: Changes in healthcare policies or regulatory environments could impact pricing. For example, increased funding for family planning programs could lead to more subsidized pricing for ANNOVERA.
Global Expansion
The Population Council is working to make ANNOVERA available worldwide, including in low- and middle-income countries where there is a significant unmet need for contraception. This global expansion could lead to economies of scale and potentially lower prices as the product reaches a broader market[4].
Key Takeaways
- Unique Selling Proposition: ANNOVERA's long-lasting, reversible, and procedure-free nature sets it apart in the contraceptive market.
- Growing Adoption: The product has seen steady growth in prescriptions and user satisfaction.
- Pricing Challenges: High costs are a significant barrier, but discount programs and patient assistance initiatives help mitigate this.
- Future Projections: Prices are likely to remain stable in the short term, with potential for adjustments based on market competition and economies of scale in the long term.
FAQs
What is ANNOVERA and how does it work?
ANNOVERA is a vaginal ring that combines segesterone acetate and ethinyl estradiol to inhibit ovulation for an entire year. It is inserted into the vagina for 21 days and then removed for 7 days to allow for a menstrual period.
How effective is ANNOVERA in preventing pregnancy?
ANNOVERA is 97.3% effective in preventing pregnancy when used as directed, based on data from Phase 3 clinical trials.
How much does ANNOVERA cost?
The cost of ANNOVERA is approximately $2,558 for one vaginal ring, although discounts and patient assistance programs can reduce this cost.
Is ANNOVERA available globally?
Currently, ANNOVERA is available in the U.S., but the Population Council is working to make it available worldwide, including in low- and middle-income countries.
What are the common side effects of ANNOVERA?
Common side effects include vaginal discharge, headache, and nausea. It also carries a boxed warning related to increased cardiovascular risk when used while smoking, similar to other combined hormonal contraceptives.
Sources
- TherapeuticsMD Receives U.S. Food and Drug Administration (FDA) Approval for ANNOVERA - TherapeuticsMD.
- Annovera Prices, Coupons, Copay Cards & Patient Assistance - Drugs.com.
- TherapeuticsMD Announces Third Quarter 2022 Financial Results - TherapeuticsMD.
- FDA Approves the First One-Year Contraceptive Fully under a Woman's Control - Population Council.
More… ↓
